All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - anticoagulant
Direct Oral Anticoagulants: Laboratory Testing
Read more...
Alternative anticoagulant treatment in patients with Heparin Induced Thrombocytopenia (HIT). Experience in a high center according to anticoagulants local availability
Read more...
Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
Read more...
How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?
Read more...
COVID-19 associated Coagulopathy: Different Approaches to Anticoagulant Therapy
Read more...
D3 - Session 5 - D-Dimer and Arterial Diseases
Read more...
D3 - Session 4 - D-Dimer in Cancer and VTE
Read more...
D3 - Session 1 - Covid19 Associated Coagulopathies: A Year in Review
Read more...
STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
Dynamic relationship between D-dimer and COVID-19 severity
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
Coagulopathy in COVID-19
Read more...
Frequency of lupus anticoagulant in COVID-19 patients
Read more...
Lupus anticoagulant is frequent in patients with Covid-19
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
Read more...
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Read more...
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Read more...
Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
Read more...
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Read more...
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Read more...
Heparin resistance in COVID-19 patients in the intensive care unit
Read more...
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Read more...
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Read more...
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
Read more...
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation
Read more...
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Read more...
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Read more...
Interaction of heparin and protamine in presence of overdosage: in vitro study
Read more...
Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation
Read more...
The temporal pattern of postoperative coagulation status in patients undergoing major liver surgery
Read more...
Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment
Read more...
Perioperative Thromboelastometry for Adult Living Donor Liver Transplant Recipients with a Tendency to Hypercoagulability: A Prospective Observational Cohort Study
Read more...
AGA Clinical Practice Update: Coagulation in Cirrhosis
Read more...
Massive transfusion in The Netherlands
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
Read more...
COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness
Read more...
The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study
Read more...
Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneumonia
Read more...
The role of rotational thromboelastometry during the COVID-19 pandemic: a narrative review
Read more...
Rotational thrombelastometry: a step forward to safer patient care?
Read more...
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Read more...
Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools
Read more...
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
Read more...
Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
Read more...
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodes in Antiphospholipid Syndrome A Multicenter Study
Read more...
Hemostasis and COVID-19
Read more...
APL panel approach testing in Antiphospholipid syndrome (APS)
Read more...
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection